148 related articles for article (PubMed ID: 22592631)
1. Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.
Khoo EY; Stevenson MC; Leverton E; Cross R; Eriksson JW; Poucher SM; Spendlove I; Morris PG; Macdonald IA; Mansell P; Aithal GP
Dig Dis Sci; 2012 Nov; 57(11):3017-25. PubMed ID: 22592631
[TBL] [Abstract][Full Text] [Related]
2. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children.
Nassef YE; Shady MM; Galal EM; Hamed MA
Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):887-93. PubMed ID: 24141960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis.
Lidbury JA; Hoffmann AR; Fry JK; Suchodolski JS; Steiner JM
Can J Vet Res; 2016 Oct; 80(4):302-308. PubMed ID: 27733785
[TBL] [Abstract][Full Text] [Related]
4. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
5. Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes.
Bril F; Leeming DJ; Karsdal MA; Kalavalapalli S; Barb D; Lai J; Rabe M; Cusi K
Diabetes Care; 2019 Jul; 42(7):1348-1351. PubMed ID: 31221701
[TBL] [Abstract][Full Text] [Related]
6. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
7. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
[TBL] [Abstract][Full Text] [Related]
8. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between liver fat content and liver enzymes in individuals with various statuses of glucose metabolism].
Bian H; Yan HM; Xia MF; Rao SX; Yao XZ; Zeng MS; Zhou J; Jia WP; Gao X
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3385-90. PubMed ID: 21223809
[TBL] [Abstract][Full Text] [Related]
10. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.
Younossi ZM; Page S; Rafiq N; Birerdinc A; Stepanova M; Hossain N; Afendy A; Younoszai Z; Goodman Z; Baranova A
Obes Surg; 2011 Apr; 21(4):431-9. PubMed ID: 20532833
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
Puigvehí M; Hernández J; Broquetas T; Coll S; Garcia-Retortillo M; Cañete N; Giménez MD; Garcia M; Bory F; Salvadó M; Solà R; Carrión JA
PLoS One; 2016; 11(12):e0164883. PubMed ID: 27984583
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
14. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.
Kawashiri SY; Origuchi T; Umeda M; Nishino A; Shimizu T; Fukui S; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Maeda T; Kawano M; Yamamoto M; Izumi Y; Kawakami A
Arthritis Res Ther; 2018 Dec; 20(1):277. PubMed ID: 30547825
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
16. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.
Kotronen A; Juurinen L; Hakkarainen A; Westerbacka J; Cornér A; Bergholm R; Yki-Järvinen H
Diabetes Care; 2008 Jan; 31(1):165-9. PubMed ID: 17934148
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
18. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
19. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis.
Rath T; Roderfeld M; Güler C; Wenzel C; Graf J; Beitinger F; Roeb E; Zachoval R
Scand J Gastroenterol; 2011 Nov; 46(11):1369-80. PubMed ID: 21905976
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
